Pasithea Therapeutics (KTTA) Non Operating Income (2021 - 2026)

Pasithea Therapeutics' Non Operating Income history runs 6 years deep, the most recent figure standing at $2.0 million for Q1 2026.

• In Q1 2026, Non Operating Income rose 28573.74% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $2.3 million (up 1245.27% YoY), while the FY2025 annual figure was $429612.0, up 24.39% from the prior year.
• Non Operating Income came in at $2.0 million for Q1 2026 at Pasithea Therapeutics, up from $145294.0 in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $2.0 million in Q1 2026 to a low of -$335317.0 in Q3 2022.
• A 5-year average of $235582.9 and a median of $94742.0 in 2025 frame the typical range for Non Operating Income.
• Across the five-year window, Non Operating Income tumbled 106.41% in 2023 and jumped 28573.74% in 2026, its largest moves.
• Pasithea Therapeutics' Non Operating Income stood at -$55594.0 in 2022, then jumped by 311.39% to $117518.0 in 2023, then slumped by 30.32% to $81889.0 in 2024, then jumped by 77.43% to $145294.0 in 2025, then jumped by 1281.45% to $2.0 million in 2026.
• According to Business Quant data, Non Operating Income over the past three periods registered $2.0 million, $145294.0, and $72635.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison